NGM Biopharmaceuticals INC
SEC CIK 1426332 · NGM · last insider filing 2024-04-08
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Goeddel David V | Director | filed 2019 - 2024 |
| Rieflin William JL | Director · Executive Chairman | filed 2019 - 2024 |
| Perlmutter Roger M | Director | filed 2021 - 2024 |
| Column Group L P | Director | filed 2019 - 2024 |
| Hooper Suzanne Sawochka | Director | filed 2019 - 2024 |
| Guyer Shelly D | Director | filed 2019 - 2024 |
| Svennilson Peter | Director | filed 2019 - 2024 |
| Woodhouse David J | Director · Chief Executive Officer | filed 2019 - 2024 |
| Ponoi Capital, LP | Director | filed 2019 - 2024 |
| Ho Carole | Director | filed 2020 - 2024 |
| Chen JIN-Long | Director · Chief Scientific Officer | filed 2019 - 2023 |
| Leschly Mark | Director | filed 2019 - 2021 |
| Tichenor Mchenry T | Director | filed 2019 - 2020 |
| Schnell David | Director | filed 2019 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Pierce Valerie L | See Remarks | filed 2021 - 2024 |
| Viret Jean-Frederic | Chief Financial Officer | filed 2023 - 2024 |
| Lieu Hsiao D | SVP, Chief Medical Officer | filed 2020 - 2024 |
| Perlich Irene | Principal Accounting Officer | filed 2023 - 2024 |
| Nolan Mangini Siobhan | President and CFO | filed 2020 - 2023 |
| Trombley Aetna Wun | President & COO | filed 2019 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.